Meta-analysis on association between the ATP-binding cassette transporter A1 gene (ABCA1) and Alzheimer's disease

Gene

Volumn 510, Issue 2, 2012, Pages 147-153

  Jiang, Mei ^a   Lv, Lei ^b   Wang, Hairong ^a   Yang, Xuelian ^a   Ji, Haifeng ^a   Zhou, Fei ^a   Zhu, Wei ^a   Cai, Liying ^a   Gu, Xiaju ^a   Sun, Jian ^a   Dong, Qiang ^b  

^a Shanghai Pudong New Area Gongli Hospital   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

ABCA1; Alzheimer's disease; Meta analysis; Polymorphisms; Susceptibility

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN E;

ALLELE; ALZHEIMER DISEASE; ARTICLE; DNA POLYMORPHISM; ETHNICITY; GENETIC MODEL; GENETIC RISK; GENETIC VARIABILITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; PRIORITY JOURNAL; SAMPLE SIZE; SENSITIVITY ANALYSIS;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ATP-BINDING CASSETTE TRANSPORTERS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, GENETIC;

EID: 84867335992     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.09.009     Document Type: Article

References (29)

1. Blacker D., et al. Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum. Mol. Genet. 2003, 12:23-32.
2. Chu L.W., et al. A novel intronic polymorphism of ABCA1 gene reveals risk for sporadic Alzheimer's disease in Chinese. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007, 144B:1007-1013.
3. Cochran W.G. The combination of estimates from different experiments. Biometrics 1954, 10:101-129.
4. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1896, 7:177-188.
5. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. Br. Med. J. 1997, 315:629-634.
6. Fan J., Donkin J., Wellington C. Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E. Biofactors 2009, 35:239-248.
7. Hollingworth P., Harold D., Jones L., Owen M.J., Williams J. Alzheimer's disease genetics: current knowledge and future challenges. Int. J. Geriatr. Psychiatry 2011, 26:793-802.
8. Huang W., Qiu C., von Strauss E., Winblad B., Fratiglioni L. APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study. Arch. Neurol. 2004, 61:1930-1934.
9. Karten B., Peake K.B., Vance J.E. Mechanisms and consequences of impaired lipid trafficking in Niemann-Pick type C1-deficient mammalian cells. Biochim. Biophys. Acta 2009, 1791:659-670.
10. Katzov H., et al. Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism. Hum. Mutat. 2004, 23:358-367.
11. Khorshid K.H.R., Kamali K.E.G., Ohadi M., Karimloo M., Shahhosseiny M.H. The association between sporadic Alzheimer's disease and the human ABCA1 and APOE gene polymorphisms in Iranian population. Iran. Red Crescent Med. J. 2011, 13:256-262.
12. Koldamova R., Staufenbiel M., Lefterov I. Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice. J. Biol. Chem. 2005, 280:43224-43235.
13. Kölsch H., et al. Polymorphism in ABCA1 influences CSF 24S-hydroxycholesterol levels but is not a major risk factor of Alzheimer's disease. Int. J. Mol. Med. 2006, 17:791-794.
14. Li Y., et al. Association of ABCA1 with late-onset Alzheimer's disease is not observed in a case-control study. Neurosci. Lett. 2004, 366:268-271.
15. Li H., et al. Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch. Neurol. 2008, 65:45-53.
16. Oram J.F., Lawn R.M. ABCA1 the gatekeeper for eliminating excess tissue cholesterol. J. Lipid Res. 2001, 42:1173-1179.
17. Richard F., Amouyel P. Genetic susceptibility factors for Alzheimer's disease. Eur. J. Pharmacol. 2001, 412:1-12.
18. Rodríguez-Rodríguez E., et al. Association of genetic variants of ABCA1 with Alzheimer's disease risk. Am. J. Med. Genet. B Neuropsychiatr. Gene. 2007, 144B:964-968.
19. Saunders A.M., et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993, 43:1467-1472.
20. Shibata N., et al. Association studies of cholesterol metabolism genes (CH25H, ABCA1 and CH24H) in Alzheimer's disease. Neurosci. Lett. 2006, 391:142-146.
21. Sun Y.M., et al. The polymorphism of the ATP-binding cassette transporter 1 gene modulates alzheimer disease risk in Chinese Han ethnic population. Am. J. Geriatr. Psychiatry 2012, 20:603-611.
22. Sundar P.D., Feingold E., Minster R.L., DeKosky S.T., Kamboh M.I. Gender-specific association of ATP-binding cassette transporter 1 (ABCA1) polymorphisms with the risk of late-onset Alzheimer's disease. Neurobiol. Aging 2007, 28:856-862.
23. Vance J.E., Hayashi H., Karten B. Cholesterol homeostasis in neurons and glial cells. Semin. Cell Dev. Biol. 2005, 16:193-212.
24. Wahrle S.E., et al. ABCA1 is required for normal central nervous system APOE levels and for lipidation of astrocyte-secreted APOE. J. Biol. Chem. 2004, 279:40987-40993.
25. Wahrle S.E., et al. Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease. J. Biol. Chem. 2005, 280:43236-43242.
26. Wahrle S.E., et al. Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms. Mol. Neurodegener. 2007, 2:7.
27. Wang F., Jia J. Polymorphisms of cholesterol metabolism genes CYP46 and ABCA1 and the risk of sporadic Alzheimer's disease in Chinese. Brain Res. 2007, 1147:34-38.
28. Wollmer M.A., et al. ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease. Neurobiol. Aging 2003, 24:421-426.
29. Wolozin B. A fluid connection: cholesterol and Ab. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:5371-5373.